Synthesis, Hemoglobin Encapsulation and Biorthogonal PEGylation in Hierarchically Porous UiO-66 Nanoparticles for Oxygen Delivery Applications
May 8th, 2026
332 views
This protocol details the synthesis, hemoglobin encapsulation, and surface PEGylation of hierarchically porous UiO-66 nanoparticles designed for oxygen delivery. The procedure combines defect engineering with strain-promoted biorthogonal conjugation to generate highly permeable and physiologically stable carriers suitable for biomedical applications.
Overview
This article presents a detailed, scalable protocol for fabricating hierarchically porous UiO-66 nanoparticles (HP-UiO-66 NPs) designed to encapsulate hemoglobin (Hb) for use as hemoglobin-based oxygen carriers (HBOCs). The protocol emphasizes reproducibility, scalability, and stability, utilizing bioorthogonal polyethylene glycol (PEG) shells to enhance nanoparticle performance and biocompatibility. The workflow is modular and adaptable for encapsulating other biomacromolecules or enzymes for therapeutic delivery.
Key Study Components
Area of Science
- Nanomaterials
- Biomaterials
- Oxygen delivery systems
- Biomedical engineering
Background
- Hemoglobin-based oxygen carriers (HBOCs) are developed to address hypoxia in biomedical applications.
- Free hemoglobin is unstable and vasoactive outside red blood cells, limiting its direct use.
- Metal-organic frameworks (MOFs), such as UiO-66, offer tunable porosity and stability for encapsulation.
- PEGylation is commonly used to improve nanoparticle stability and biocompatibility.
Purpose of Study
- To provide a reproducible, step-by-step protocol for fabricating HP-UiO-66 NPs encapsulating Hb.
- To enhance the stability and oxygen-carrying capacity of encapsulated Hb using PEG shells.
- To detail troubleshooting strategies and critical parameters for inter-laboratory reproducibility.
Methods Used
- Defect engineering of UiO-66-NH2 nanoparticles via dodecanoic acid modulation and acid washing.
- Surface amine conversion to azides for subsequent bioorthogonal chemistry.
- Encapsulation of hemoglobin in buffered aqueous media.
- PEGylation using catalyst-free strain-promoted alkyne-azide cycloaddition (SPAAC).
- Comprehensive physicochemical characterization (crystallinity, porosity, surface chemistry, PEG corona).
- Functional assays for oxygenation/deoxygenation of encapsulated Hb.
Main Results
- Gram-scale production of HP-UiO-66-NH2 NPs per batch is achievable.
- Encapsulation efficiencies of ~35% (loading content ~24 wt%) for Hb under mild conditions.
- PEGylated NPs exhibit a hydrodynamic diameter of ~140 nm and low polydispersity.
- Physicochemical analyses confirm framework integrity, mesoporosity, and successful PEGylation.
- Encapsulated Hb retains reversible oxygenation/deoxygenation capacity.
- PEGylation significantly improves colloidal and structural stability in various biological media.
Conclusions
- The protocol enables robust, scalable fabrication of MOF-based HBOCs with high encapsulation efficiency and stability.
- PEGylation is critical for maintaining nanoparticle integrity and function in physiological environments.
- The workflow is modular and adaptable for other therapeutic biomacromolecules or enzymes.
Frequently Asked Questions
What are hemoglobin-based oxygen carriers (HBOCs)?
HBOCs are engineered systems designed to transport oxygen in biomedical contexts, serving as alternatives to red blood cells or for mitigating hypoxia.
Why is PEGylation important in this protocol?
PEGylation enhances the colloidal and structural stability of the nanoparticles, preventing degradation and improving biocompatibility in physiological media.
How is hierarchical porosity introduced into UiO-66 nanoparticles?
Hierarchical mesoporosity is achieved through dodecanoic acid modulation followed by acid washing, resulting in HP-UiO-66-NH2 nanoparticles with preserved crystallinity.
What encapsulation efficiency is achieved for hemoglobin?
The protocol achieves approximately 35% encapsulation efficiency, corresponding to a loading content of about 24 wt% for hemoglobin.
How is hemoglobin loaded and stabilized within the nanoparticles?
Hemoglobin is loaded in buffered aqueous media and stabilized by a PEG shell formed via strain-promoted alkyne-azide cycloaddition (SPAAC) on azide-functionalized nanoparticles.
Can this protocol be adapted for other biomacromolecules?
Yes, the modular workflow is readily adaptable for encapsulating other biomacromolecules or enzymes that require protective yet accessible microenvironments for therapeutic delivery.
What are the main troubleshooting strategies included?
The protocol details critical experimental parameters, standard failure modes, and troubleshooting strategies at each stage to enhance reproducibility across laboratories.
